Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Cyclin-Dependent Protein Kinase
More Information »Cdks (cyclin-dependent kinases) are heteromeric serine/threonine kinases that control progression through the cell cycle in concert with their regulatory subunits, the cyclins. Although there are 12 different cdk genes, only 5 have been shown to directly drive the cell cycle.
Cyclin-Dependent Protein Kinase Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 2072 | Aminopurvalanol A |
| Cyclin-dependent kinase inhibitor | |
| 2457 | Arcyriaflavin A |
| Potent cdk4/cyclin D1 and CaM Kinase II inhibitor. Antiviral agent (anti-HCMV) | |
| 3968 | AZD 5438 |
| Potent cyclin-dependent kinase (cdk) 1, 2 and 9 inhibitor | |
| 3605 | (R)-CR8 |
| Dual cdk1/cdk5 inhibitor. Also inhibits CK1 | |
| 3610 | (R)-DRF053 dihydrochloride |
| Dual cdk1/cdk5 inhibitor. Also inhibits CK1 | |
| 3094 |
Flavopiridol hydrochloride
|
| Cyclin-dependent kinase inhibitor | |
| 1813 | Indirubin-3'-oxime |
| Cyclin-dependent kinase inhibitor. Also inhibits other protein kinases | |
| 1398 | Kenpaullone |
| Potent cyclin-dependent kinase inhibitor. Also inhibits GSK-3 | |
| 2152 | NSC 625987 |
| Cyclin-dependent kinase 4 (cdk4) inhibitor | |
| 1867 | NSC 663284 |
| Cdc25 phosphatase inhibitor; blocks cdk1 and cdk2 activation | |
| 1937 | NSC 693868 |
| Cdk inhibitor. Also inhibits GSK-3 | |
| 3135 | NU 2058 |
| Cdk1 and cdk2 inhibitor | |
| 3301 | NU 6140 |
| Cyclin-dependent kinase 2 (cdk2) inhibitor | |
| 1284 | Olomoucine |
| Cyclin-dependent kinase inhibitor | |
| 1902 | [Ala92]-p16 (84-103) |
| Cyclin-dependent kinase inhibitor | |
| 4786 |
PD 0332991 isethionate
|
| Potent, selective Cdk4/6 inhibitor; brain penetrant | |
| 3140 | PHA 767491 hydrochloride |
| Dual cdc7/cdk9 inhibitor. Also inhibits MK2 | |
| 1580 | Purvalanol A |
| Cyclin-dependent kinase inhibitor | |
| 1581 | Purvalanol B |
| Cyclin-dependent kinase inhibitor | |
| 4181 | Ro 3306 |
| Cyclin-dependent kinase (cdk) 1 inhibitor | |
| 2609 | Ryuvidine |
| Cyclin-dependent kinase 4 (cdk4) inhibitor | |
| 4075 | SNS 032 |
| Potent cdk2, cdk7 and cdk9 inhibitor | |
| 2907 | SU 9516 |
| Potent cdk2 inhibitor | |
Blockers |
|
Cat.No. |
Product Name / Activity |
| 1532 |
10Z-Hymenialdisine
|
| Pan kinase inhibitor; potently inhibits Cdk1, Cdk2, Cdk3 and Cdk5 | |
Related Categories
Quick Order
Find multiple products by catalog number
Tocris Events
Meet your representative
The Role of Cytokines and Signaling in Inflammation
October 15, 2013
Bonn, Germany





